PSA value at 2 years post-treatment can predict long-term survival in prostate cancer patients

(American Society for Radiation Oncology) Prostate cancer patients who have a prostate-specific antigen value of less than or equal to 1.5 at two years after external beam radiation therapy are less likely to have a cancer recurrence and cancer-related death, according to a study in the December 1 issue of the International Journal of Radiation Oncology, Biology, Physics, the official journal of the American Society for Radiation Oncology.

source : www.eurekalert.org

Related News:

• SGO: New Option for Recurrent Ovarian Cancer?
• Accelerating The Pace Of Discovery In Cancer Research
• SGO: New Option for Recurrent Ovarian Cancer? (CME/CE)
• Impact Of Ethnicity On Primary Treatment Choice And Mortality In Men With Prostate Cancer: Data From CaPSURE
• Gaps Remain in Cancer Palliative Care (CME/CE)
• Cordyceps mushroom is an effective cancer treatment, states new research
• Insufficiency Fractures After Pelvic Radiotherapy In Patients With Prostate Cancer
• Genetic variations influence statin efficacy for lowering colon cancer risk
• Heart transplant patients face greater risk of skin cancer
• How Cells Protect Themselves From Cancer